Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity
F Kamin(University of Rostock), Uwe K. Zettl(University of Rostock), Paulus Rommer(Medical University of Vienna), R. Benecke(Children's Hospital of Philadelphia), Alexander Winkelmann(University of Rostock), Mazen Abu‐Mugheisib(University of Rostock), F. Hoffmann(Martha-Maria Hospital), Wolfgang Köehler(Fachkrankenhaus Hubertusburg)
Cited by 19
Related Papers
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
|Journal of Neuroinflammation|2016|896
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
|Annals of Neurology|2015|436
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
|Journal of Neuroinflammation|2016|433
Transcranial magnetic stimulation of the human brain: responses in muscles supplied by cranial nerves
|Experimental Brain Research|1988|304
On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects
|Experimental Brain Research|1993|303